Page last updated: 2024-10-29

ketanserin and Endotoxemia

ketanserin has been researched along with Endotoxemia in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walther, A2
Petri, E1
Peter, C2
Czabanka, M1
Martin, E2
Secchi, A1
Gebhard, MM1
Schmidt, H1

Other Studies

2 other studies available for ketanserin and Endotoxemia

ArticleYear
Selective serotonin-receptor antagonism and microcirculatory alterations during experimental endotoxemia.
    The Journal of surgical research, 2007, Volume: 143, Issue:2

    Topics: Animals; Blood Flow Velocity; Cell Communication; Endothelium, Vascular; Endotoxemia; Ketanserin; Le

2007
Selective serotonin receptor antagonism and leukocyte-independent plasma extravasation during endotoxemia.
    Microvascular research, 2002, Volume: 63, Issue:1

    Topics: Animals; Binding Sites; Cinanserin; Endothelium, Vascular; Endotoxemia; Extravasation of Diagnostic

2002